» Articles » PMID: 38207109

Toward the Scalable, Rapid, Reproducible, and Cost-Effective Synthesis of Personalized Nanomedicines at the Point of Care

Overview
Journal Nano Lett
Specialty Biotechnology
Date 2024 Jan 11
PMID 38207109
Authors
Affiliations
Soon will be listed here.
Abstract

Organic nanoparticles are used in nanomedicine, including for cancer treatment and some types of COVID-19 vaccines. Here, we demonstrate the scalable, rapid, reproducible, and cost-effective synthesis of three model organic nanoparticle formulations relevant to nanomedicine applications. We employed a custom-made, low-cost fluid mixer device constructed from a commercially available three-dimensional printer. We investigated how systematically changing aqueous and organic volumetric flow rate ratios determined liposome, polymer nanoparticle, and solid lipid nanoparticle sizes, size distributions, and payload encapsulation efficiencies. By manipulating inlet volumes, we synthesized organic nanoparticles with encapsulation efficiencies approaching 100% for RNA-based payloads. The synthesized organic nanoparticles were safe and effective at the cell culture level, as demonstrated by various assays. Such cost-effective synthesis approaches could potentially increase the accessibility to clinically relevant organic nanoparticle formulations for personalized nanomedicine applications at the point of care, especially in nonhospital and low-resource settings.

Citing Articles

A translational framework to DELIVER nanomedicines to the clinic.

Joyce P, Allen C, Alonso M, Ashford M, Bradbury M, Germain M Nat Nanotechnol. 2024; 19(11):1597-1611.

PMID: 39242807 DOI: 10.1038/s41565-024-01754-7.

References
1.
Groner J, Tognazzi M, Walter M, Fleischmann D, Mietzner R, Ziegler C . Encapsulation of Pioglitazone into Polymer-Nanoparticles for Potential Treatment of Atherosclerotic Diseases. ACS Appl Bio Mater. 2023; 6(6):2111-2121. DOI: 10.1021/acsabm.2c01001. View

2.
Erfle P, Riewe J, Bunjes H, Dietzel A . Stabilized Production of Lipid Nanoparticles of Tunable Size in Taylor Flow Glass Devices with High-Surface-Quality 3D Microchannels. Micromachines (Basel). 2019; 10(4). PMC: 6523713. DOI: 10.3390/mi10040220. View

3.
Hartl N, Adams F, Costabile G, Isert L, Doblinger M, Xiao X . The Impact of Nylon-3 Copolymer Composition on the Efficiency of siRNA Delivery to Glioblastoma Cells. Nanomaterials (Basel). 2019; 9(7). PMC: 6669510. DOI: 10.3390/nano9070986. View

4.
Zhang G, Sun J . Lipid in Chips: A Brief Review of Liposomes Formation by Microfluidics. Int J Nanomedicine. 2021; 16:7391-7416. PMC: 8575451. DOI: 10.2147/IJN.S331639. View

5.
Cheng Q, Wei T, Farbiak L, Johnson L, Dilliard S, Siegwart D . Selective organ targeting (SORT) nanoparticles for tissue-specific mRNA delivery and CRISPR-Cas gene editing. Nat Nanotechnol. 2020; 15(4):313-320. PMC: 7735425. DOI: 10.1038/s41565-020-0669-6. View